Related Experiment Video
Updated: Jun 30, 2026
06:28
Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration
Published on: February 2, 2024
799
Polymers in Engineering Extracellular Vesicle Mimetics: Current Status and Prospective.
Xinyue Wei1, Sihang Liu1,2, Yifeng Cao1,3
1Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China.
Pharmaceutics
|May 27, 2023
Summary
Polymer-engineered extracellular vesicle mimics (EVMs) offer improved cancer drug delivery efficiency. This review explores their design and function for advanced nanomedicine applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- Traditional nanomedicines face challenges in maintaining high drug delivery efficiency for cancer treatment.
- Extracellular vesicles (EVs) show promise due to low immunogenicity and high targeting ability, but have limitations.
- Polymer-engineered extracellular vesicle mimics (EVMs) are emerging as a solution to overcome EV limitations.
Purpose of the Study:
- To review the current status of polymer-based extracellular vesicle mimics in cancer drug delivery.
- To analyze the structural and functional properties of EVMs as ideal drug carriers.
- To provide insights for advancing EVM-based drug delivery systems.
Main Methods:
- Literature review of polymer-based extracellular vesicle mimics in cancer therapy.
- Analysis of structural and functional properties of EVMs.
- Comparison with ideal drug carrier design principles.
Main Results:
- Polymer-engineered EVMs demonstrate potential for enhanced drug loading and targeted delivery in cancer therapy.
- EVMs offer a tunable platform to overcome the inherent limitations of natural EVs.
- The design of EVMs can be optimized based on ideal drug carrier characteristics.
Conclusions:
- Polymer-based EVMs represent a promising advancement in nanomedicine for cancer treatment.
- Further understanding of EVM design and function will accelerate their clinical translation.
- EVMs hold significant potential to improve drug delivery efficiency and therapeutic outcomes in oncology.
Related Concept Videos
01:36Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...